# FDA Inspection 1028538 - Glenmark Pharmaceuticals Ltd - August 26, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-ltd/4a9b33f4-46ae-4dd5-ac8d-e581ed33dbeb/
Source feed: FDA_Inspections

> FDA Inspection 1028538 for Glenmark Pharmaceuticals Ltd on August 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028538
- Company Name: Glenmark Pharmaceuticals Ltd
- Inspection Date: 2017-08-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1260403 - 2025-02-14](https://www.globalkeysolutions.net/api/records/fda_inspections/glenmark-pharmaceuticals-ltd/135e2ceb-8fc0-4f1b-85f4-7dd2405c8793/)
- [FDA Inspection 1260403 - 2025-02-14](https://www.globalkeysolutions.net/api/records/fda_inspections/glenmark-pharmaceuticals-ltd/3c60fd16-c7cf-4f81-84b6-49d9b508a8a5/)
- [FDA Inspection 1122868 - 2020-02-25](https://www.globalkeysolutions.net/api/records/fda_inspections/glenmark-pharmaceuticals-ltd/d660f074-743b-4d49-9676-d23b1a8f3af3/)
- [FDA Inspection 1107098 - 2019-09-13](https://www.globalkeysolutions.net/api/records/fda_inspections/glenmark-pharmaceuticals-ltd/71212f99-083e-4703-bd7e-29af24033c10/)
- [FDA Inspection 1053034 - 2018-05-24](https://www.globalkeysolutions.net/api/records/fda_inspections/glenmark-pharmaceuticals-ltd/d58dd996-cd4c-4c93-a806-807c622ee6c3/)

Company: https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-ltd/1e6c03ca-7a68-4506-9af3-70d64338538a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
